メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

犬の幹細胞治療の世界市場

Global Market Study on Canine Stem Cell Therapy: Ongoing Clinical Trials and Focus on Advancements to Push Adoption in Veterinary Clinics

発行 Persistence Market Research 商品コード 640963
出版日 ページ情報 英文 230 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.44円で換算しております。
Back to Top
犬の幹細胞治療の世界市場 Global Market Study on Canine Stem Cell Therapy: Ongoing Clinical Trials and Focus on Advancements to Push Adoption in Veterinary Clinics
出版日: 2018年04月16日 ページ情報: 英文 230 Pages
概要

当レポートでは犬の幹細胞治療の世界市場を取り上げ、市場成長促進要因や阻害要因、市場動向、また市場競争状況に関する広範な調査を通じて市場の現状分析ならびに将来予測を行っています。さらに市場を製品タイプ別、適応症別、エンドユーザ別、および地域/国別に分類し、それぞれ詳細な分析と予測とを提供しています。

第1章 エグゼクティブ・サマリー

  • 市場概要
  • 市場分析
  • PMRの分析および提言
  • 将来見通し

第2章 市場序説

  • 市場の定義
  • 市場分類

第3章 犬の幹細胞治療市場の機会分析

  • マクロ経済要因
  • 市場機会分析

第4章 市場の背景

  • 獣医学における幹細胞治療の進化
  • 市場ダイナミクス
  • 法規制シナリオ

第5章 重要添付データ

  • 主要製造企業一覧
  • 価格分析

第6章 北米における犬の幹細胞治療市場分析および将来予測

  • 序論
  • 国別市場規模履歴分析
  • 国別市場規模予測
  • 製品タイプ別市場規模履歴分析
  • 製品タイプ別市場規模予測
  • 適応症別市場規模動向履歴分析
  • 適応症別市場規模予測
  • エンドユーザ別市場規模動向履歴分析
  • エンドユーザ別市場規模予測
  • 市場成長促進要因および阻害要因:影響度分析
  • 市場魅力度分析
  • 重要事項

第7章 ラテンアメリカにおける犬の幹細胞治療市場分析および将来予測

第8章 欧州における犬の幹細胞治療市場分析および将来予測

第9章 アジア太平洋地域 (日本を除く) における犬の幹細胞治療市場分析および将来予測

第10章 日本における犬の幹細胞治療市場分析および将来予測

第11章 中東・アフリカ地域における犬の幹細胞治療市場分析および将来予測

第12章 予測要因:関連性と影響度

第13章 予測についての想定条件

第14章 主要企業プロファイル

  • 企業詳細

第15章 犬の幹細胞治療の世界市場の地域別分析および将来予測

  • 序論/重要な調査結果
  • 地域別市場規模動向履歴分析
  • 地域別市場規模予測

第16章 犬の幹細胞治療の世界市場の製品タイプ別分析および将来予測

  • 序論/重要な調査結果
  • 製品タイプ別市場規模動向履歴分析
  • 製品タイプ別市場規模予測
  • 製品タイプ別市場魅力度分析

第17章 犬の幹細胞治療の世界市場の適応症別分析および将来予測

  • 序論/重要な調査結果
  • 適応症別市場規模動向履歴分析
  • 適応症別市場規模予測
  • 適応症別市場魅力度分析

第18章 犬の幹細胞治療の世界市場のエンドユーザ別分析および将来予測

  • 序論/重要な調査結果
  • エンドユーザ別市場規模動向履歴分析
  • エンドユーザ別市場規模予測
  • エンドユーザ別市場魅力度分析

第19章 犬の幹細胞治療の世界市場分析および将来予測

  • 全市場分類毎の市場価値シェア分析
  • 全市場分類毎の対前年比成長率分析
  • 確定的市場機会金額
目次

A synopsis of the global canine stem cell therapy market with reference to the global healthcare pharmaceutical industry

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

  • Parent Indicators Healthcare
  • Current expenditure on health, % of gross domestic product
  • Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
  • Annual growth rate of current expenditure on health, per capita, in real terms
  • Out-of-pocket expenditure, % of current expenditure on health
  • Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
  • Physicians, Density per 1000 population (head counts)
  • Nurses, Density per 1000 population (head counts)
  • Total hospital beds, per 1000 population
  • Curative (acute) care beds, per 1000 population
  • Medical technology, Magnetic Resonance Imaging units, total, per million population
  • Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

PMR utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Standard Report Structure

  • Executive Summary
  • Market Definition
  • Macro-economic analysis
  • Parent Market Analysis
  • Market Overview
  • Forecast Factors
  • Segmental Analysis and Forecast
  • Regional Analysis
  • Competition Analysis
  • Target Audience
  • Production Companies
  • Suppliers
  • Channel Partners
  • Marketing Authorities
  • Subject Matter Experts
  • Research Institutions
  • Financial Institutions
  • Market Consultants
  • Government Authorities
  • Market Taxonomy

The global canine stem cell therapy market has been segmented into:

  • Product Type:
  • Allogeneic Stem Cells
  • Autologous Stem cells
  • Application:
  • Arthritis
  • Dysplasia
  • Tendonitis
  • Lameness
  • Others
  • End User:
  • Veterinary Hospitals
  • Veterinary Clinics
  • Veterinary Research Institutes
  • Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Japan
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Canine Stem Cell Therapy Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis

4. Market Background

  • 4.1. Evolution of Stem Cell Therapy In Veterinary
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunity Analysis
  • 4.3. Regulatory Scenario

5. Key Inclusions

  • 5.1. Key Manufacturer List
  • 5.2. Pricing Analysis

6. North America Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn) Analysis By Country, 2012-2016
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
  • 6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
    • 6.4.1. Autologous Stem Cell
    • 6.4.2. Allogeneic Stem Cell
  • 6.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
  • 6.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 6.6.1. Arthritis
    • 6.6.2. Lameness
    • 6.6.3. Dysplasia
    • 6.6.4. Tendonitis
    • 6.6.5. Others
  • 6.7. Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
    • 6.8.1. Veterinary Hospitals
    • 6.8.2. Veterinary Clinics
    • 6.8.3. Veterinary Research Institutes
  • 6.9. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 6.10. Drivers and Restraints: Impact Analysis
  • 6.11. Market Attractiveness Analysis
    • 6.11.1. By Country
    • 6.11.2. By Product Type
    • 6.11.3. By Application
    • 6.11.4. By End User
  • 6.12. Key Takeaways

7. Latin America Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) Trends Analysis By Country, 2012-2016
    • 7.2.1. Argentina
    • 7.2.2. Brazil
    • 7.2.3. Mexico
    • 7.2.4. Rest of Latin America
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
  • 7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
    • 7.4.1. Autologous Stem Cell
    • 7.4.2. Allogeneic Stem Cell
  • 7.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
  • 7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 7.6.1. Arthritis
    • 7.6.2. Lameness
    • 7.6.3. Dysplasia
    • 7.6.4. Tendonitis
    • 7.6.5. Others
  • 7.7. Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
    • 7.8.1. Veterinary Hospitals
    • 7.8.2. Veterinary Clinics
    • 7.8.3. Veterinary Research Institutes
  • 7.9. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 7.10. Drivers and Restraints: Impact Analysis
  • 7.11. Market Attractiveness Analysis
    • 7.11.1. By Country
    • 7.11.2. By Product Type
    • 7.11.3. By Application
    • 7.11.4. By End User
  • 7.12. Key Takeaways

8. Europe Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2016
    • 8.2.1. Germany
    • 8.2.2. U.K.
    • 8.2.3. France
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Russia
    • 8.2.7. Rest of Europe
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
  • 8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
    • 8.4.1. Autologous Stem Cell
    • 8.4.2. Allogeneic Stem Cell
  • 8.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
  • 8.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 8.6.1. Arthritis
    • 8.6.2. Lameness
    • 8.6.3. Dysplasia
    • 8.6.4. Tendonitis
    • 8.6.5. Others
  • 8.7. Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
    • 8.8.1. Veterinary Hospitals
    • 8.8.2. Veterinary Clinics
    • 8.8.3. Veterinary Research Institutes
  • 8.9. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 8.10. Drivers and Restraints: Impact Analysis
  • 8.11. Market Attractiveness Analysis
    • 8.11.1. By Country
    • 8.11.2. By Product Type
    • 8.11.3. By Application
    • 8.11.4. By End User
  • 8.12. Key Takeaways

9. APEJ Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2016
    • 9.2.1. Japan
    • 9.2.2. India
    • 9.2.3. Australia and New Zealand
    • 9.2.4. Rest of APEJ
  • 9.3. Market Size (US$ Mn) Forecast By Country, 2017-2025
  • 9.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
    • 9.4.1. Autologous Stem Cell
    • 9.4.2. Allogeneic Stem Cell
  • 9.5. Market Size (US$ Mn) Forecast By Product Type, 2017-2025
  • 9.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 9.6.1. Arthritis
    • 9.6.2. Lameness
    • 9.6.3. Dysplasia
    • 9.6.4. Tendonitis
    • 9.6.5. Others
  • 9.7. Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
    • 9.8.1. Veterinary Hospitals
    • 9.8.2. Veterinary Clinics
    • 9.8.3. Veterinary Research Institutes
  • 9.9. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 9.10. Drivers and Restraints: Impact Analysis
  • 9.11. Market Attractiveness Analysis
    • 9.11.1. By Country
    • 9.11.2. By Product Type
    • 9.11.3. By Application
    • 9.11.4. By End User
  • 9.12. Key Takeaways

10. Japan Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025

  • 10.1.Introduction
  • 10.2.Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
    • 10.2.1. Autologous Stem Cell
    • 10.2.2. Allogeneic Stem Cell
  • 10.3.Market Size (US$ Mn) Forecast By Product Type, 2017-2025
  • 10.4.Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 10.4.1. Arthritis
    • 10.4.2. Lameness
    • 10.4.3. Dysplasia
    • 10.4.4. Tendonitis
    • 10.4.5. Others
  • 10.5.Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 10.6.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
    • 10.6.1. Veterinary Hospitals
    • 10.6.2. Veterinary Clinics
    • 10.6.3. Veterinary Research Institutes
  • 10.7. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 10.8. Drivers and Restraints: Impact Analysis
  • 10.9. Market Attractiveness Analysis
    • 10.9.1. By Product Type
    • 10.9.2. By Application
    • 10.9.3. By End User
  • 10.10. Key Takeaways

11. Middle East & Africa Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025

  • 11.1.Introduction
  • 11.2.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012-2016
    • 11.2.1. GCC Countries
    • 11.2.2. South Africa
    • 11.2.3. Rest of MEA
  • 11.3.Market Size (US$ Mn) Forecast By Country, 2017-2025
  • 11.4.Historical Market Size (US$ Mn) Analysis By Product Type, 2012-2016
    • 11.4.1. Autologous Stem Cell
    • 11.4.2. Allogeneic Stem Cell
  • 11.5.Market Size (US$ Mn) Forecast By Product Type, 2017-2025
  • 11.6.Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 11.6.1. Arthritis
    • 11.6.2. Lameness
    • 11.6.3. Dysplasia
    • 11.6.4. Tendonitis
    • 11.6.5. Others
  • 11.7.Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 11.8.Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
    • 11.8.1. Veterinary Hospitals
    • 11.8.2. Veterinary Clinics
    • 11.8.3. Veterinary Research Institutes
  • 11.9. Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 11.10. Drivers and Restraints: Impact Analysis
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Country
    • 11.11.2. By Product Type
    • 11.11.3. By Application
    • 11.11.4. By End User
  • 11.12. Key Takeaways

12. Forecast Factors: Relevance and Impact

13. Forecast Assumptions

14. Company Profiles

  • 14.1.Company Deep Dive
    • 14.1.1. VETSTEM BIOPHARMA
      • 14.1.1.1. Overview
      • 14.1.1.2. Product and Application Portfolio
      • 14.1.1.3. Production Footprint
      • 14.1.1.4. Sales Footprint
      • 14.1.1.5. Channel Footprint
      • 14.1.1.6. Strategy
        • 14.1.1.6.1.1. Marketing Strategy
        • 14.1.1.6.1.2. Product Strategy
        • 14.1.1.6.1.3. Channel Strategy
    • 14.1.2. Aratana Therapeutics
      • 14.1.2.1. Overview
      • 14.1.2.2. Product and Application Portfolio
      • 14.1.2.3. Production Footprint
      • 14.1.2.4. Sales Footprint
      • 14.1.2.5. Channel Footprint
      • 14.1.2.6. Strategy
        • 14.1.2.6.1.1. Marketing Strategy
        • 14.1.2.6.1.2. Product Strategy
        • 14.1.2.6.1.3. Channel Strategy
    • 14.1.3. Medivet Biologics LLC
      • 14.1.3.1. Overview
      • 14.1.3.2. Product and Application Portfolio
      • 14.1.3.3. Production Footprint
      • 14.1.3.4. Sales Footprint
      • 14.1.3.5. Channel Footprint
      • 14.1.3.6. Strategy
        • 14.1.3.6.1.1. Marketing Strategy
        • 14.1.3.6.1.2. Product Strategy
        • 14.1.3.6.1.3. Channel Strategy
    • 14.1.4. Okyanos
      • 14.1.4.1. Overview
      • 14.1.4.2. Product and Application Portfolio
      • 14.1.4.3. Production Footprint
      • 14.1.4.4. Sales Footprint
      • 14.1.4.5. Channel Footprint
      • 14.1.4.6. Strategy
        • 14.1.4.6.1.1. Marketing Strategy
        • 14.1.4.6.1.2. Product Strategy
        • 14.1.4.6.1.3. Channel Strategy
    • 14.1.5. Vetbiologics
      • 14.1.5.1. Overview
      • 14.1.5.2. Product and Application Portfolio
      • 14.1.5.3. Production Footprint
      • 14.1.5.4. Sales Footprint
      • 14.1.5.5. Channel Footprint
      • 14.1.5.6. Strategy
        • 14.1.5.6.1.1. Marketing Strategy
        • 14.1.5.6.1.2. Product Strategy
        • 14.1.5.6.1.3. Channel Strategy
    • 14.1.6. VetMatrix
      • 14.1.6.1. Overview
      • 14.1.6.2. Product and Application Portfolio
      • 14.1.6.3. Production Footprint
      • 14.1.6.4. Sales Footprint
      • 14.1.6.5. Channel Footprint
      • 14.1.6.6. Strategy
        • 14.1.6.6.1.1. Marketing Strategy
        • 14.1.6.6.1.2. Product Strategy
        • 14.1.6.6.1.3. Channel Strategy
    • 14.1.7. Magellan Stem Cells
      • 14.1.7.1. Overview
      • 14.1.7.2. Product and Application Portfolio
      • 14.1.7.3. Production Footprint
      • 14.1.7.4. Sales Footprint
      • 14.1.7.5. Channel Footprint
      • 14.1.7.6. Strategy
        • 14.1.7.6.1.1. Marketing Strategy
        • 14.1.7.6.1.2. Product Strategy
        • 14.1.7.6.1.3. Channel Strategy
    • 14.1.8. ANIMAL CELL THERAPIES, INC
      • 14.1.8.1. Overview
      • 14.1.8.2. Product and Application Portfolio
      • 14.1.8.3. Production Footprint
      • 14.1.8.4. Sales Footprint
      • 14.1.8.5. Channel Footprint
      • 14.1.8.6. Strategy
        • 14.1.8.6.1.1. Marketing Strategy
        • 14.1.8.6.1.2. Product Strategy
        • 14.1.8.6.1.3. Channel Strategy
    • 14.1.9. stemcellvet.co.uk
      • 14.1.9.1. Overview
      • 14.1.9.2. Product and Application Portfolio
      • 14.1.9.3. Production Footprint
      • 14.1.9.4. Sales Footprint
      • 14.1.9.5. Channel Footprint
      • 14.1.9.6. Strategy
        • 14.1.9.6.1.1. Marketing Strategy
        • 14.1.9.6.1.2. Product Strategy
        • 14.1.9.6.1.3. Channel Strategy
    • 14.1.10. Cell Therapy Sciences
      • 14.1.10.1. Overview
      • 14.1.10.2. Product and Application Portfolio
      • 14.1.10.3. Production Footprint
      • 14.1.10.4. Sales Footprint
      • 14.1.10.5. Channel Footprint
      • 14.1.10.6. Strategy
        • 14.1.10.6.1.1. Marketing Strategy
        • 14.1.10.6.1.2. Product Strategy
        • 14.1.10.6.1.3. Channel Strategy
    • 14.1.11. Regeneus Ltd.
      • 14.1.11.1. Overview
      • 14.1.11.2. Product and Application Portfolio
      • 14.1.11.3. Production Footprint
      • 14.1.11.4. Sales Footprint
      • 14.1.11.5. Channel Footprint
      • 14.1.11.6. Strategy
        • 14.1.11.6.1.1. Marketing Strategy
        • 14.1.11.6.1.2. Product Strategy
        • 14.1.11.6.1.3. Channel Strategy

15. Global Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025, By Region

  • 15.1. Introduction/Key Findings
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012-2016
  • 15.3. Market Size (US$ Mn) Forecast By Region, 2017-2025
    • 15.3.1. North America
    • 15.3.2. Latin America
    • 15.3.3. Europe
    • 15.3.4. APEJ
    • 15.3.5. Middle East & Africa
    • 15.3.6. Japan
  • 15.4.Market Attractiveness Analysis By Region

16. Global Canine Stem Cell Therapy Analysis 2012-2016 and Forecast 2017-2025, By Product Type

  • 16.1. Introduction/Key Findings
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2012-2016
    • 16.2.1. Autologous Stem Cell
    • 16.2.2. Allogeneic Stem Cell
  • 16.3.Market Size (US$ Mn) Forecast By Product Type, 2017-2025
  • 16.4.Market Attractiveness Analysis By Product Type

17. Global Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025, By Application

  • 17.1. Introduction/Key Findings
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2012-2016
    • 17.2.1. Arthritis
    • 17.2.2. Lameness
    • 17.2.3. Dysplasia
    • 17.2.4. Tendonitis
    • 17.2.5. Others
  • 17.3.Market Size (US$ Mn) Forecast By Application, 2017-2025
  • 17.4.Market Attractiveness Analysis By Application

18. Global Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025, By End User

  • 18.1. Introduction/Key Findings
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012-2016
    • 18.2.1. Veterinary Hospitals
    • 18.2.2. Veterinary Clinics
    • 18.2.3. Veterinary Research Institutes
  • 18.3.Market Size (US$ Mn) Forecast By End User, 2017-2025
  • 18.4.Market Attractiveness Analysis By End User

19. Global Canine Stem Cell Therapy Market Analysis 2012-2016 and Forecast 2017-2025

  • 19.1.Market Value Share Analysis By All Segment
  • 19.2.Y-o-Y Growth Analysis By All Segment
  • 19.3.Absolute $ Opportunity

List of Table

  • Table 01: Global Key Company and Product Mapping
  • Table 02: Canine Stem Cell Therapy Average Cost (US$/Therapy), By Product Type
  • Table 03: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Country
  • Table 04: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product
  • Table 05: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
  • Table 06: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End User
  • Table 07: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Country
  • Table 08: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product
  • Table 09: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
  • Table 10: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End User
  • Table 11: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Country
  • Table 12: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product
  • Table 13: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
  • Table 14: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End User
  • Table 15: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Country
  • Table 16: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product
  • Table 17: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
  • Table 18: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End User
  • Table 19: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product
  • Table 20: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
  • Table 21: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End User
  • Table 22: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Country
  • Table 23: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product
  • Table 24: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
  • Table 25: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End User
  • Table 26: Global Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Region
  • Table 27: Global Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Product Type
  • Table 28: Global Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By Application
  • Table 29: Global Canine Stem Cell Therapy Market size (US$ Mn) Analysis 2014-2017 and Forecast 2018-2026, By End Use

List of Figures

  • Figure 01: Canine Stem Cell Therapy Market Revenue Share by Product Type 2018E & 2026F
  • Figure 02: Canine Stem Cell Therapy Market Revenue Share by End User, 2018E & 2026F
  • Figure 03: Global Market Value Share 2018E, By Application Type
  • Figure 04: Global Canine Stem Cell Market Revenue Opportunity Analysis, By Region 2018-2026
  • Figure 05: U.S. Estimated Breakdown of Pet Industry Expenditure (US$ Bn), By Service 2017
  • Figure 06: Total U.S. Pet Industry Expenditures (US$ Bn), 2017
  • Figure 07: U.S. Consumer Spending (US$ Bn) on Veterinary Care
  • Figure 08: Global Canine Stem Cell Therapy Average Price, 2017 - 2020
  • Figure 09: North America Canine Stem Cell Therapy Market Value Share (2017A)
  • Figure 10: North America Canine Stem Cell Therapy Market Value Share (2017A), By Country
  • Figure 11: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 12: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 13: U.S. Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 14: U.S. Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 15: Canada Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 16: Canada Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 17: North America Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 18: North America Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 19: North America Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 20: North America Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 21: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014-2017
  • Figure 22: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018-2026
  • Figure 23: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014-2017
  • Figure 24: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018-2026
  • Figure 25: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
  • Figure 26: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
  • Figure 27: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014-2017
  • Figure 28: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018-2026
  • Figure 29: North America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014-2017
  • Figure 30: North America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018-2026
  • Figure 31: North America Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
  • Figure 32: North America Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
  • Figure 33: North America Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
  • Figure 34: North America Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
  • Figure 35: Latin America Canine Stem Cell Therapy Market Value Share (2017A)
  • Figure 36: Latin America Canine Stem Cell Therapy Market Value Share (2017A), By Country
  • Figure 37: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 38: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 39: Brazil Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 40: Brazil Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 41: Mexico Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 42: Mexico Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 43: Rest of Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 44: Rest of Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 45: Latin America Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 46: Latin America Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 47: Latin America Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 48: Latin America Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 49: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014-2017
  • Figure 50: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018-2026
  • Figure 51: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014-2017
  • Figure 52: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018-2026
  • Figure 53: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
  • Figure 54: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
  • Figure 55: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014-2017
  • Figure 56: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018-2026
  • Figure 57: Latin America Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014-2017
  • Figure 58: Latin America Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018-2026
  • Figure 59: Latin America Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
  • Figure 60: Latin America Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
  • Figure 61: Latin America Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
  • Figure 62: Latin America Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
  • Figure 63: Europe Canine Stem Cell Therapy Market Value Share (2017A)
  • Figure 64: Europe Canine Stem Cell Therapy Market Value Share (2017A), By Country
  • Figure 65: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 66: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 67: Germany Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 68: Germany Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 69: U.K. Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 70: U.K. Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 71: France Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 72: France Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 73: Italy Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 74: Italy Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 75: Spain Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 76: Spain Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 77: Russia Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 78: Russia Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 79: Rest of Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 80: Rest of Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 81: Europe Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 82: Europe Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 83: Europe Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 84: Europe Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 85: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014-2017
  • Figure 86: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018-2026
  • Figure 87: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014-2017
  • Figure 88: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018-2026
  • Figure 89: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
  • Figure 90: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
  • Figure 91: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014-2017
  • Figure 92: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018-2026
  • Figure 93: Europe Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014-2017
  • Figure 94: Europe Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018-2026
  • Figure 95: Europe Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
  • Figure 96: Europe Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
  • Figure 97: Europe Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
  • Figure 98: Europe Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
  • Figure 99: APEJ Canine Stem Cell Therapy Market Value Share (2017A)
  • Figure 100: APEJ Canine Stem Cell Therapy Market Value Share (2017A), By Country
  • Figure 101: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 102: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 103: India Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 104: India Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 105: Australia & New Zealand Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 106: Australia & New Zealand Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 107: Rest of APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 108: Rest of APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 109: APEJ Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 110: APEJ Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 111: APEJ Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 112: APEJ Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 113: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014-2017
  • Figure 114: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018-2026
  • Figure 115: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014-2017
  • Figure 116: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018-2026
  • Figure 117: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
  • Figure 118: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
  • Figure 119: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014-2017
  • Figure 120: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018-2026
  • Figure 121: APEJ Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014-2017
  • Figure 122: APEJ Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018-2026
  • Figure 123: APEJ Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
  • Figure 124: APEJ Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
  • Figure 125: APEJ Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
  • Figure 126: APEJ Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
  • Figure 127: Japan Canine Stem Cell Therapy Market Value Share (2017A)
  • Figure 128: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 129: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 130: Japan Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 131: Japan Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 132: Japan Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 133: Japan Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 134: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014-2017
  • Figure 135: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018-2026
  • Figure 136: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014-2017
  • Figure 137: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018-2026
  • Figure 138: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
  • Figure 139: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
  • Figure 140: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014-2017
  • Figure 141: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018-2026
  • Figure 142: Japan Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
  • Figure 143: Japan Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
  • Figure 144: Asia Pacific Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
  • Figure 145: Japan Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
  • Figure 146: Japan Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
  • Figure 147: Middle East & Africa Canine Stem Cell Therapy Market Value Share (2017A)
  • Figure 148: Middle East & Africa Canine Stem Cell Therapy Market Value Share (2017A), By Country
  • Figure 149: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 150: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 151: GCC Countries Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 152: GCC Countries Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 153: South Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 154: South Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 155: Rest of Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 156: Rest of Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 157: Middle East & Africa Allogeneic Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 158: Middle East & Africa Allogeneic Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 159: Middle East & Africa Autologous Stem Cell Therapy Market size (US$ Mn) Analysis, 2014-2017
  • Figure 160: Middle East & Africa Autologous Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
  • Figure 161: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Arthritis, 2014-2017
  • Figure 162: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Arthritis, 2018-2026
  • Figure 163: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Dysplasia, 2014-2017
  • Figure 164: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Dysplasia, 2018-2026
  • Figure 165: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Tendonitis, 2014-2017
  • Figure 166: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Tendonitis, 2018-2026
  • Figure 167: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Lameness, 2014-2017
  • Figure 168: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Lameness, 2018-2026
  • Figure 169: Middle East & Africa Canine Stem Cell Therapy Market size (US$ Mn) Analysis, By Others, 2014-2017
  • Figure 170: Middle East & Africa Canine Stem Cell Therapy Market Value (US$ Mn) & Y-o-Y Growth (%), By Others, 2018-2026
  • Figure 171: Middle East & Africa Canine Stem Cell Therapy Market Attractiveness Analysis, By Product Type
  • Figure 172: Middle East & Africa Canine Stem Cell Therapy Market Attractiveness Analysis, By Application
  • Figure 173: Middle East & Africa Canine Stem Cell Therapy Market Attractiveness Analysis, By End User
  • Figure 174: Middle East & Africa Canine Stem Cell Therapy Market Attractiveness Analysis, By Country
  • Figure 175: Global Canine Stem Cell Therapy Market Share Analysis (%) By Region, 2018 & 2026
  • Figure 176: Global Canine Stem Cell Therapy Market Y-o-Y Growth (%) By Region, 2018-2026
  • Figure 177: Global Canine Stem Cell Therapy Market Attractiveness Analysis By Region, 2018-2026
  • Figure 178: Global Canine Stem Cell Therapy Market Share Analysis (%) By Product Type, 2018 & 2026
  • Figure 179: Global Canine Stem Cell Therapy Market Y-o-Y Growth (%) By Product Type, 2018-2026
  • Figure 180: Global Canine Stem Cell Therapy Market Attractiveness Analysis By Product Type, 2018-2026
  • Figure 181: Global Canine Stem Cell Therapy Market Share Analysis (%) By Application, 2018 & 2026
  • Figure 182: Global Canine Stem Cell Therapy Market Y-o-Y Growth (%) By Application, 2018-2026
  • Figure 183: Global Canine Stem Cell Therapy Market Attractiveness Analysis By Application, 2018-2026
  • Figure 184: Global Canine Stem Cell Therapy Market Share Analysis (%) By End User, 2018 & 2026
  • Figure 185: Global Canine Stem Cell Therapy Market Y-o-Y Growth (%) By End User, 2018-2026
  • Figure 186: Global Canine Stem Cell Therapy Market Attractiveness Analysis By End User, 2018-2026
  • Figure 187: Global Canine Stem Cell Therapy Market Value Analysis and Forecast, 2017-2026 (US$ Mn)
  • Figure 188: Global Canine Stem Cell Therapy Market Value (US$ Mn), 2014-2017
  • Figure 189: Global Canine Stem Cell Therapy Market Absolute $ Opportunity (US$ Mn), 2017-2026
Back to Top